Cure Alzheimer's Fund: Targeting Breakthrough Research

Despite advances in understanding the pathology of Alzheimer’s disease, advancements in its diagnosis and treatment are limited. To address this key need, researchers at the University of Texas Health Science Center at Houston (UTHealth) and the University of Houston(UH) have been awarded a $150,0... (Read more)

National Alzheimer’s Disease Research Strategy Prepared by:   Rudolph E. Tanzi, Ph.D. Chairperson, Cure Alzheimer’s Fund Research Consortium Joseph P. and Rose F. Kennedy Professor of Neurology Harvard Medical School Director, Genetics and Aging Unit, MassGeneral Institute for Neuorodeg... (Read more)

This project will further explore evidence that the Abeta peptide, acknowledged to be implicated in the cause of AD, may be an anti-microbial agent. More relevant articles: Glabe Paper Helps Confirm Prana Drug Strategy Amyloid beta protein may be a defense against Microbes! Drs. Rob Moir and... (Read more)